Medtronic Tangible Asset Value vs Enterprise Value Analysis
MDT Stock | USD 80.38 0.91 1.12% |
Medtronic PLC financial indicator trend analysis is infinitely more than just investigating Medtronic PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medtronic PLC is a good investment. Please check the relationship between Medtronic PLC Tangible Asset Value and its Enterprise Value accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.
Tangible Asset Value vs Enterprise Value
Tangible Asset Value vs Enterprise Value Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medtronic PLC Tangible Asset Value account and Enterprise Value. At this time, the significance of the direction appears to have no relationship.
The correlation between Medtronic PLC's Tangible Asset Value and Enterprise Value is 0.0. Overlapping area represents the amount of variation of Tangible Asset Value that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Medtronic PLC, assuming nothing else is changed. The correlation between historical values of Medtronic PLC's Tangible Asset Value and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Tangible Asset Value of Medtronic PLC are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Tangible Asset Value i.e., Medtronic PLC's Tangible Asset Value and Enterprise Value go up and down completely randomly.
Correlation Coefficient | 0.0 |
Relationship Direction | Flat |
Relationship Strength | Insignificant |
Tangible Asset Value
The total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks.Enterprise Value
Enterprise Value (or EV) is usually referred to as Medtronic PLC theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Medtronic PLC debt, but would also pocket its cash. Enterprise Value is more accurate representation of Medtronic PLC value than its market capitalization because it takes into account all of Medtronic PLC existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from Medtronic PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 458.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 21.5B | 20.5B | 23.6B | 24.8B | Total Revenue | 31.7B | 31.2B | 35.9B | 37.7B |
Medtronic PLC fundamental ratios Correlations
Click cells to compare fundamentals
Medtronic PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medtronic PLC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 90.7B | 93.1B | 91.0B | 90.9B | 104.6B | 109.8B | |
Short Long Term Debt Total | 24.8B | 26.4B | 24.1B | 24.4B | 28.0B | 29.4B | |
Other Current Liab | 5.6B | 6.1B | 6.1B | 6.1B | 7.0B | 7.3B | |
Total Current Liabilities | 10.4B | 8.5B | 12.4B | 9.1B | 10.4B | 10.9B | |
Total Stockholder Equity | 50.7B | 51.4B | 52.6B | 51.5B | 59.2B | 62.2B | |
Property Plant And Equipment Net | 4.8B | 5.2B | 5.4B | 5.6B | 6.4B | 6.7B | |
Net Debt | 20.7B | 22.8B | 20.4B | 22.8B | 26.2B | 27.6B | |
Retained Earnings | 28.1B | 28.6B | 30.3B | 30.4B | 35.0B | 36.7B | |
Cash | 4.1B | 3.6B | 3.7B | 1.5B | 1.8B | 1.6B | |
Non Current Assets Total | 68.7B | 70.5B | 67.9B | 69.3B | 79.7B | 83.6B | |
Non Currrent Assets Other | 1.6B | 1.7B | 2.0B | 2.3B | 2.7B | 2.8B | |
Cash And Short Term Investments | 10.9B | 10.8B | 10.6B | 8.0B | 9.2B | 4.8B | |
Net Receivables | 4.6B | 5.5B | 5.6B | 6.0B | 6.9B | 7.2B | |
Common Stock Shares Outstanding | 1.4B | 1.4B | 1.4B | 1.3B | 1.5B | 1.2B | |
Liabilities And Stockholders Equity | 90.7B | 93.1B | 91.0B | 90.9B | 104.6B | 109.8B | |
Non Current Liabilities Total | 29.5B | 33.0B | 25.9B | 30.2B | 34.8B | 36.5B | |
Inventory | 4.2B | 4.3B | 4.6B | 5.3B | 6.1B | 6.4B | |
Other Current Assets | 2.2B | 2.0B | 2.3B | 2.4B | 2.8B | 2.9B | |
Other Stockholder Equity | 26.2B | 26.3B | 24.6B | 24.6B | 28.3B | 29.7B | |
Total Liab | 39.8B | 41.5B | 38.3B | 39.3B | 45.2B | 47.4B | |
Total Current Assets | 22.0B | 22.5B | 23.1B | 21.7B | 24.9B | 26.2B | |
Short Term Debt | 2.8B | 11M | 3.7B | 20M | 23M | 21.9M | |
Intangible Assets | 19.1B | 17.7B | 15.6B | 14.8B | 17.1B | 17.9B | |
Accounts Payable | 2.0B | 2.1B | 2.3B | 2.7B | 3.1B | 3.2B | |
Other Liab | 6.7B | 5.8B | 5.5B | 6.8B | 7.8B | 3.9B | |
Other Assets | 2.1B | 3.5B | 1M | (1M) | (1.2M) | (1.1M) | |
Long Term Debt | 22.0B | 26.4B | 20.4B | 24.3B | 28.0B | 29.4B | |
Good Will | 39.8B | 42.0B | 40.5B | 41.4B | 47.6B | 50.0B | |
Short Term Investments | 6.8B | 7.2B | 6.9B | 6.4B | 7.4B | 5.0B | |
Accumulated Other Comprehensive Income | (3.6B) | (3.5B) | (2.3B) | (3.5B) | (3.1B) | (3.0B) | |
Common Stock | 134.1K | 134.5K | 133.1K | 133.1K | 119.8K | 113.8K | |
Property Plant Equipment | 4.8B | 6.2B | 5.4B | 6.6B | 7.6B | 8.0B | |
Property Plant And Equipment Gross | 5.8B | 5.2B | 13.4B | 14.1B | 16.2B | 17.0B | |
Short Long Term Debt | 2.8B | 11M | 3.7B | 20M | 18M | 17.1M | |
Net Tangible Assets | 50.7B | (8.3B) | (3.5B) | 51.5B | 59.2B | 62.2B | |
Deferred Long Term Liab | 1.2B | 1.0B | 884M | 708M | 637.2M | 605.3M | |
Noncontrolling Interest In Consolidated Entity | 135M | 174M | 171M | 182M | 209.3M | 123.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.